Evaluating the role of <scp>Day</scp> 14 bone marrow biopsy and <scp>European LeukemiaNet</scp> risk classification in predicting overall and relapse‐free survival in acute myeloid leukemia

Metodi Balev, Victor Zibara, Grace Van Hyfte, Jonathan Feld, Marina Kremyanskaya, Michelle Becker, Alla Keyzner, Alan H. Shih, Bridget Marcellino, Hannah Levavi, Lewis Silverman, John Mascarenhas, Douglas Tremblay

doi:HTTPS://DOI.ORG/https://doi.org/10.1002/ajh.27429

Evaluating the role of <scp>Day</scp> 14 bone marrow biopsy and <scp>European LeukemiaNet</scp> risk classification in predicting overall and relapse‐free survival in acute myeloid leukemia

Authors: Metodi Balev, Victor Zibara, Grace Van Hyfte, Jonathan Feld, Marina Kremyanskaya, Michelle Becker, Alla Keyzner, Alan H. Shih, Bridget Marcellino, Hannah Levavi, Lewis Silverman, John Mascarenhas, Douglas Tremblay

Published: 2024-07-06

DOI: HTTPS://DOI.ORG/https://doi.org/10.1002/ajh.27429

Keywords: No keywords found.

Abstract:
No abstract found.

Source: